Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure

How to buy MetLife stock

Learn how to easily invest in MetLife stock.

MetLife is an insurance-life business based in the US. MetLife shares (MET) are listed on the NYSE and all prices are listed in US Dollars.

How to buy MetLife stock

  1. Choose a stock trading platform. Use our comparison table or choose from our Top Picks below.
  2. Open an account. Provide your personal information and sign up.
  3. Fund your account. Deposit funds unto your account by linking your banking information or transfer funds from another trading account.
  4. Search for the stock name – MET. Search for the stock by name or ticker symbol.
  5. Buy the stock. Place your order. It's that simple.

Best for low fees

Finder Award

SoFi Invest

  • Trade stocks for $0 and no annual fee
  • Start trading with a $0 minimum deposit
  • Get up to $1,000 when you fund a new account within 30 days

Best for beginners

Finder Award


  • Easy to use platform with low fees
  • Social trading allows you to copy popular portfolios
  • FINDER EXCLUSIVE: Get $15 when you sign up and deposit $100

Promoted for easy user experience


  • Get free stock upon signup
  • Earn 4% interest on uninvested cash with Robinhood Gold
  • Get 1% match on contributions to a Robinhood IRA

MetLife stock price (NYSE: MET)

Use our graph to track the performance of MET stocks over time.

MetLife shares at a glance

Information last updated 2023-02-08.
Latest market close$71.26
52-week range$56.17 - $76.81
50-day moving average $72.57
200-day moving average $67.51
Wall St. target price$83.43
PE ratio 24.488
Dividend yield $1.98 (2.85%)
Earnings per share (TTM) $2.91

Buy MetLife stocks from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
1 - 6 of 6
Name Product Available asset types Stock trade fee Minimum deposit Signup bonus
SoFi Invest
Stocks, Options, ETFs, Cryptocurrency
Get up to $1,000
when you fund a new account within 30 days.
Winner of Finder’s Best Low-Cost Broker award.
Finder Award
Stocks, Options, ETFs, Cryptocurrency
when you sign up and deposit $100
Winner of Finder’s Best Broker for Beginners award. Not available in NY, NV, MN, TN, and HI.
Stocks, Options, ETFs, Cryptocurrency
Get a free stock
when you successfully sign up and link your bank account.
Make unlimited commission-free trades, plus earn 4% interest on uninvested cash in your account with Robinhood Gold.
Stocks, Options, ETFs, Cryptocurrency
Get $200 in US stocks
when you open and fund an account with min. $2,000 for 3+ mos.
Highly commended for Best Derivatives Trading Platform award.
Stocks, ETFs, Cryptocurrency, Alternatives
Get up to $300 in either stocks or crypto
when you use code FINDERUS to sign up and fund a new account.
Trade stocks and ETFs commission-free, plus gain access to alternative investments like art, NFTs and more.
Interactive Brokers
Stocks, Bonds, Options, Mutual funds, ETFs, Cryptocurrency, Futures, Forex
Winner of Finder’s Best Overall Stock Broker award.

Compare up to 4 providers

Information on this page is for educational purposes only. Finder is not an advisor or brokerage service, and we don't recommend investors to trade specific stocks or other investments.

Finder is not a client of any featured partner. We may be paid a fee for referring prospective clients to a partner, though it is not a recommendation to invest in any one partner.

Is it a good time to buy MetLife stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

MetLife price performance over time

Historical closes compared with the close of $71.26 from 2023-02-07

1 week (2023-02-02) 2.22%
1 month (2023-01-05) N/A
3 months (2022-11-09) -2.08%
6 months (2022-08-05) N/A
1 year (2022-02-09) 1.19%
2 years (2021-02-09) 32.94%
3 years (2020-02-07) 48.25%
5 years (2018-02-08) 92.89%

Is MetLife stock undervalued or overvalued?

Valuing MetLife stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of MetLife's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

MetLife's P/E ratio

MetLife's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 24x. In other words, MetLife shares trade at around 24x recent earnings.

That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.

MetLife's PEG ratio

MetLife's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 5.1936. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.

The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into MetLife's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.

MetLife's EBITDA

MetLife's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $4 billion.

The EBITDA is a measure of a MetLife's overall financial performance and is widely used to measure a its profitability.

MetLife financials

Revenue TTM $69.9 billion
Operating margin TTM 5.61%
Gross profit TTM $15.6 billion
Return on assets TTM 0.34%
Return on equity TTM 5.38%
Profit margin 3.63%
Book value $34.71
Market capitalisation $55.5 billion

TTM: trailing 12 months

MetLife share dividends


Dividend payout ratio: 29.24% of net profits

Recently MetLife has paid out, on average, around 29.24% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 2.85% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), MetLife shareholders could enjoy a 2.85% return on their shares, in the form of dividend payments. In MetLife's case, that would currently equate to about $1.98 per share.

While MetLife's payout ratio might seem fairly standard, it's worth remembering that MetLife may be investing much of the rest of its net profits in future growth.

MetLife's most recent dividend payout was on 13 March 2023. The latest dividend was paid out to all shareholders who bought their shares by 5 February 2023 (the "ex-dividend date").

Have MetLife's shares ever split?

MetLife's shares were split on a 1122:1000 basis on 6 August 2017. So if you had owned 1000 shares the day before before the split, the next day you'd have owned 1122 shares. This wouldn't directly have changed the overall worth of your MetLife shares – just the quantity. However, indirectly, the new 10.9% lower share price could have impacted the market appetite for MetLife shares which in turn could have impacted MetLife's share price.

MetLife share price volatility

Over the last 12 months, MetLife's shares have ranged in value from as little as $56.1669 up to $76.8058. A popular way to gauge a stock's volatility is its "beta".

MET.US volatility(beta: 1.08)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while MetLife's is 1.0805. This would suggest that MetLife's shares are a little bit more volatile than the average for this exchange and represent, relatively-speaking, a slightly higher risk (but potentially also market-beating returns).

MetLife overview

MetLife, Inc. , a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through five segments: U. S. ; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements. It also provides pension risk transfers, institutional income annuities, structured settlements, and capital markets investment products; and other products and services, such as life insurance products and funding agreements for funding postretirement benefits, as well as company, bank, or trust-owned life insurance used to finance nonqualified benefit programs for executives.

Frequently asked questions

What percentage of MetLife is owned by insiders or institutions?
Currently 15.969% of MetLife shares are held by insiders and 75.665% by institutions.
When does the fiscal year end for MetLife?
MetLife's fiscal year ends in December.
Where is MetLife based?
MetLife's address is: 200 Park Avenue, New York, NY, United States, 10166-0188
What is MetLife's ISIN number?
MetLife's international securities identification number is: US59156R1086
What is MetLife's CUSIP number?
MetLife's Committee on Uniform Securities Identification Procedures number is: 59156R116

More guides on Finder

Ask an Expert provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and Terms of Use.

Questions and responses on are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site